
Denmark’s Novo Nordisk has opened a new manufacturing facility in Russia to produce more of its diabetes offerings in the …

Novo Nordisk is recalling around 3 million insulin products used to treat diabetes in Europe because of a possible manufacturing …
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care

